Navigation Links
Flexible Filling and Adoption of ‘Ready-to-Use’ Technologies to be Discussed by Catalent Biologics at the Pharma Forum
Date:9/11/2019

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that Alex Haig, Senior Director, Engineering will present at the Pharma Forum, to be held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, Germany, on Sept. 18-19, 2019.

On Wednesday, Sept. 18 at 10:45 a.m., Mr. Haig will present “Flexible Filling and Ready-to-Use Adoption in Biologics – Journey and Lessons Learned,” where he will discuss Catalent’s use of ‘ready-to-use’ (RTU) vials and cartridges and its application of next generation robotics technology for filling flexibility. He will also highlight important design elements that will help define future concepts, and discuss the market-changing technological and supply chain innovations that have been made possible by the RTU packaging components.

Mr. Haig oversees engineering, maintenance, facilities, and large capital projects at Catalent Biologics’ largest facility in Bloomington, Indiana. He joined the company in 2014, with more than 18 years’ experience in drug substance and drug product operations, and provides leadership in aseptic manufacturing, operational excellence, engineering, maintenance, utilities, and capital project management. He has a bachelor’s degree in mechanical engineering from Drexel University, Philadelphia, and a Six Sigma Black Belt certification from Villanova University.

For further information on this event, visit https://biologics.catalent.com/events/pharma-forum. To arrange a meeting with Mr. Haig, contact Richard Kerns at NEPR - richard(at)nepr.agency

About Catalent Biologics
For more than two decades, Catalent Biologics has built capabilities and experience in development, manufacturing, and analytical services for new biological entities, gene therapies, biosimilars, and antibody-drug conjugates. Catalent has worked with 600+ mAbs and 80+ proteins, and more than 115 clinical trials and 11 marketed products have used GPEx® cell line engineering technology. A further 20 commercially-approved products have employed Catalent Biologics’ capabilities through to aseptic fill/finish. Catalent’s latest addition, Paragon Gene Therapy’s AAV development through commercial-scale manufacturing facilities in Baltimore, Maryland, has produced over 100 clinical GMP batches across 40 programs. Using advanced protein improvement technology and tailored solutions from DNA through to clinical and commercial supply, Catalent Biologics brings better biologic treatments to patients, faster. For more information, visit biologics.catalent.com

About Catalent
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/flexible_filling_and_adoption_of_ready_to_use_technologies_to_be_discussed_by_catalent_biologics_at_the_pharma_forum/prweb16561430.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. SSCI’s Flexible Scientist Program (FSP) Extends Value-Added Analytical and Solid-State Chemistry Services to Customers
2. Flexible Equipment for Grocery Service Counters and Checkout Weighing Areas Displayed at NACS 2017
3. Global Printed and Flexible Sensor Industry
4. Flexible Equipment for Grocery Service Counters and Checkout Weighing Areas Displayed at NACS 2015
5. The North American flexible display market and is expected to reach $1329.6 million by 2018 - New Report by MicroMarket Monitor
6. Greener, low-cost transistor heralds advance in flexible electronics
7. Future flexible electronics based on carbon nanotubes
8. FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics
9. Cirrascale® Expands Flexible Datacenter Offerings with Support for Intel® Xeon® Processor E5-2600/1600 v3 Product Families
10. Research team finds way to make solar cells thin, efficient and flexible
11. NJIT professor invents a flexible battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2019)... ... August 28, 2019 , ... ... DuPont™ Danisco® ingredient solutions to attendees at the International Baking Industry Expo, September ... baking challenges from optimizing production efficiency to cost and waste reduction and from ...
(Date:8/25/2019)... VEGAS (PRWEB) , ... August 23, 2019 , ... ... with International No. 1 best-selling status for the scientific research book “Impact of ... in the cosmetic and perfume industry as Patchouli. , The book garnered ...
(Date:8/14/2019)... ... August 13, 2019 , ... INDIGO Biosciences, Inc. (INDIGO), ... announced the appointment of Mark McLoughlin to the Company’s Board of Directors. Mark ... will lend his healthcare expertise and extensive background in laboratory and scientific products ...
(Date:8/6/2019)... , ... August 06, 2019 , ... ... (LSMR) have joined forces in launching the biweekly SDBN BUZZ podcast focused on ... SDBN BUZZ podcast will also serve to promote the region and attract external ...
Breaking Biology Technology:
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... VISTAAR ... as a primary strategy or as re-assurance / 2nd opinion to their internal strategies ... , Lot of users when going into new markets, or planning to change their ...
(Date:9/14/2019)... ... September 13, 2019 , ... Two studies presented ... non-invasive real-time tracking of gene therapy and advances to decrease nerve damage using ... cases fatal) lysomal storage diseases (LSD) are among the most dismal of prognosis ...
(Date:9/8/2019)... JOLLA, Calif. (PRWEB) , ... September 06, 2019 ... ... the Board of Directors of Nanosens Innovations have each authorized the respective companies ... become a subsidiary of Cardea, with the Nanosens brand representing a series of ...
Breaking Biology News(10 mins):